中医药防治慢性阻塞性肺疾病的临床应用及作用机制研究进展OA
Research progress on clinical application and action mechanism of TCM in prevention and treatment of chronic obstructive pulmonary disease
慢性阻塞性肺疾病(COPD)的病理机制复杂,目前的干预策略难以遏制疾病整体进展.中医药基于辨证论治的治疗策略,围绕 COPD 本虚标实的核心病机论治,展现出多靶点、整体调节的独特优势.该文系统梳理了 COPD 的病理机制及中医药治疗的临床和基础研究进展,通过对其中医病因病机与现代病理改变的综合分析,总结了中医药防治COPD 的临床疗效,并深入阐述其作用机制.临床研究表明,补肺健脾类、补肺益肾类、清热化痰类等中药复方,以及针灸、穴位贴敷、穴位注射等外治法,可有效改善患者咳嗽、咳痰、气短等症状,减少急性加重次数,提高肺功能及运动耐量,显著提升患者生活质量.基础研究表明,中药所含的黄酮类、皂苷类、多糖类等多种活性成分及复方,通过干预核因子-κB(NF-κB)/NOD 样受体热蛋白结构域相关蛋白 3(NLRP3)、转化生长因子-β(TGF-β)/Smad 蛋白(Smad)、核因子 E2 相关因子 2(Nrf2)/血红素加氧酶-1(HO-1)、磷脂酰肌醇 3-激酶(PI3K)/蛋白激酶 B(Akt)等多条信号通路及靶点,发挥抑制炎症反应、减轻氧化应激、改善气道重塑、调节蛋白酶-抗蛋白酶失衡、调控程序性细胞死亡等多途径保护作用.此外,该文亦指出当前研究领域中存在的不足,以期为 COPD的综合防治及中医药现代化研究提供新的理论依据和研究思路.
The pathological mechanisms of chronic obstructive pulmonary disease(COPD)are complex,and current intervention strategies are difficult to control the overall progression of the disease.Guided by the treatment principle of syndrome differentiation and treatment,TCM treats COPD based on the core pathogenesis of deficiency in origin and excess in superficiality,showing the unique advantages of multiple targets and holistic regulation.This paper systematically summarized the pathological mechanisms of COPD and the clinical and basic research progress of TCM treatment.Based on the comprehensive analysis of the etiology,pathogenesis,and modern pathological changes of COPD,this paper also summarized the clinical efficacy of TCM in the prevention and treatment of COPD and elaborated its action mechanism in depth.Clinical studies have shown that TCM compound formulas with the effects of tonifying the lungs and strengthening the spleen,nourishing the lungs and kidneys,clearing heat and dissolving phlegm,as well as external treatment methods such as acupuncture,acupoint application,and acupoint injection,can effectively improve the symptoms of cough,phlegm,shortness of breath,reduce the number of acute exacerbations,improve lung function and exercise tolerance,and significantly improve the quality of life of patients.At the level of basic research,a variety of active components such as flavonoids,saponins,and polysaccharides contained in TCM,as well as compound formulas play a protective role by intervening with multiple signaling pathways and targets,including nuclear factor-κB(NF-κB)/NOD-like receptor family pyrin domain-containing 3(NLRP3),transforming growth factor-β(TGF-β)/Smad,nuclear factor erythroid 2-related factor 2(Nrf2)/heme oxygenase-1(HO-1),and phosphatidylinositol 3-kinase(PI3K)/protein kinase B(Akt),thereby exerting multi-pathway protective effects in inhibiting inflammatory responses,alleviating oxidative stress,improving airway remodeling,regulating protease-antiprotease imbalance,and modulating programmed cell death.In addition,this paper pointed out the shortcomings in the current research field,aiming to provide new theoretical bases and research ideas for the comprehensive prevention and treatment of COPD and the modernized research of TCM.
孟青婷;朱虹宇;胡嘉怡;杨程;童佳兵;李泽庚;杨勤军
安徽中医药大学,安徽 合肥 230038安徽中医药大学,安徽 合肥 230038安徽中医药大学,安徽 合肥 230038安徽中医药大学 第一附属医院,安徽 合肥 230031安徽中医药大学 第一附属医院,安徽 合肥 230031中医药防治肺系重大疾病应用转化安徽省重点实验室,安徽 合肥 230031||安徽中医药大学 第一附属医院,安徽 合肥 230031安徽中医药大学,安徽 合肥 230038||中医药防治肺系重大疾病应用转化安徽省重点实验室,安徽 合肥 230031
慢性阻塞性肺疾病中医药临床应用基础研究研究进展
chronic obstructive pulmonary diseaseTCMclinical applicationbasic researchresearch progress
《中国中药杂志》 2026 (18)
5170-5184,15
国家自然科学基金区域创新重点项目(U20A20398)国家自然科学基金面上项目(82374399)2024年度高等学校科研计划项目(2024AH051047)安徽省中医药传承创新科研项目(2024CCCX077)
评论